# Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease

> **NCT04482413** · PHASE2 · UNKNOWN · sponsor: **Nature Cell Co. Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** AstroStem
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04482413
- **Lead sponsor:** Nature Cell Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-12-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04482413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04482413, "Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04482413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*